全文获取类型
收费全文 | 10362篇 |
免费 | 1193篇 |
国内免费 | 48篇 |
专业分类
耳鼻咽喉 | 106篇 |
儿科学 | 374篇 |
妇产科学 | 264篇 |
基础医学 | 1487篇 |
口腔科学 | 225篇 |
临床医学 | 1138篇 |
内科学 | 2046篇 |
皮肤病学 | 143篇 |
神经病学 | 777篇 |
特种医学 | 727篇 |
外国民族医学 | 10篇 |
外科学 | 1368篇 |
综合类 | 278篇 |
一般理论 | 5篇 |
预防医学 | 877篇 |
眼科学 | 222篇 |
药学 | 715篇 |
1篇 | |
中国医学 | 10篇 |
肿瘤学 | 830篇 |
出版年
2022年 | 82篇 |
2021年 | 168篇 |
2020年 | 99篇 |
2019年 | 174篇 |
2018年 | 216篇 |
2017年 | 164篇 |
2016年 | 155篇 |
2015年 | 203篇 |
2014年 | 233篇 |
2013年 | 333篇 |
2012年 | 401篇 |
2011年 | 470篇 |
2010年 | 260篇 |
2009年 | 294篇 |
2008年 | 404篇 |
2007年 | 420篇 |
2006年 | 412篇 |
2005年 | 379篇 |
2004年 | 341篇 |
2003年 | 340篇 |
2002年 | 342篇 |
2001年 | 313篇 |
2000年 | 312篇 |
1999年 | 279篇 |
1998年 | 220篇 |
1997年 | 204篇 |
1996年 | 209篇 |
1995年 | 164篇 |
1994年 | 159篇 |
1993年 | 163篇 |
1992年 | 236篇 |
1991年 | 204篇 |
1990年 | 182篇 |
1989年 | 204篇 |
1988年 | 199篇 |
1987年 | 188篇 |
1986年 | 206篇 |
1985年 | 205篇 |
1984年 | 120篇 |
1983年 | 126篇 |
1982年 | 94篇 |
1981年 | 95篇 |
1980年 | 87篇 |
1979年 | 130篇 |
1978年 | 108篇 |
1977年 | 94篇 |
1976年 | 114篇 |
1974年 | 99篇 |
1973年 | 117篇 |
1972年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 248 毫秒
11.
Computed tomography findings in gastrointestinal involvement by opportunistic organisms in acquired immune deficiency syndrome 总被引:1,自引:0,他引:1
R T Greyson-Fleg B Jones E K Fishman S R Hamilton S S Siegelman 《The Journal of computed tomography》1986,10(2):175-181
The computed tomography findings in two cases of gastrointestinal superinfection by opportunistic organisms in acquired immune deficiency syndrome are presented. Findings included thickening of the mucosal folds and the bowel wall in the small intestine and colon associated with cytomegalovirus and cryptosporidiosis. These cases indicate that it is important to look carefully at the gastrointestinal tract when performing computed tomography in this group of patients. Unsuspected bowel pathology may be demonstrated, or disease may be confirmed in clinically suspected cases. 相似文献
12.
13.
ME BURGE AM JOSHUA CM McNEIL R HUI MJ BOYER R ABRAHAM 《Asia-Pacific Journal of Clinical Oncology》2005,1(1):47-52
Background: Pemetrexed and cisplatin have recently been shown to significantly improve survival compared with cisplatin alone. However, there are only limited data reflecting teaching hospital experience outside a clinical trial. Pemetrexed has only been available in Australia on a restricted basis since 2002. We reviewed our experience of patients treated on the Australian ‘Special Access Scheme’ at three major thoracic oncology units. Methods: Charts were reviewed for all patients enrolled on the scheme. Data was extracted on age, World Health Organization (WHO) performance status, histology, prior therapy, time from diagnosis to starting pemetrexed, chemotherapy (pemetrexed alone or with a platinum), cycle number, response rate, actuarial progression‐free and overall survival. Doses were cisplatin 75 mg/m2 or carboplatin AUC = 5 and pemetrexed 500 mg/m2 every 21 days. Results: 52 patients (32 male and 20 female) were reviewed. Median age was 58 years and 88% were WHO 0–1. Histology included 54% epithelial, 17% biphasic (epithelial and sarcomatoid) and 21% undefined. The median time from diagnosis to administration of pemetrexed was 145 days. Sixty‐five percent had minimal surgical intervention with video assisted thoracoscopy, pleurodesis and biopsy, while 19% had received prior palliative radiation. Seventy‐one percent were chemotherapy naïve, the remaining 29% having received previous platinum and/or gemcitabine regimens. Twenty‐three percent had pemetrexed alone, 35% in combination with carboplatin and 42% with cisplatin. The median number of cycles was 4 (range 1–13). The response rate was 33%. No toxicity was observed in 20% grade 3–4 toxicity in 10% (majority nausea/vomiting). The median progression‐free and overall survival times from starting pemetrexed were 184 days and 298 days, respectively. Conclusions: Pemetrexed‐based regimens are safe and effective in a community setting in malignant mesothelioma. 相似文献
14.
15.
Lymphangitis carcinomatosis has a grave prognosis. We report a case from carcinoma of the breast that responded completely and durably to chemotherapy. 相似文献
16.
From 1970 to 1980, 153 patients with stages A2, B1 and B2 prostatic cancer and proved negative pelvic lymph nodes underwent radical prostatectomy (84 underwent radical perineal and 69 underwent radical retropubic prostatectomy). Seventeen patients were lost to followup. Of 136 patients who were followed for 5 years or until death 128 (94 per cent) were alive at 5 years, including 118 (87 per cent) who were without evidence of recurrence. Patients with microscopic invasion of the prostatic capsule have a better outcome at 5 years than those with microscopic involvement of the seminal vesicles. Only 46 of the patients could be assessed at 10 years or had died 6 to 10 years postoperatively. Results at 10 years are considered preliminary, since many more patients will reach the 10-year milestone within the next few years. 相似文献
17.
18.
19.
20.